A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).
Saved in:
| Title: | A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). |
|---|---|
| Authors: | Capdevila, Jaume1 (AUTHOR) jcapdevila@vhio.net, Pubul, Virginia2 (AUTHOR), Anido, Urbano3 (AUTHOR), Walter, Thomas4 (AUTHOR), Molina-Cerrillo, Javier5 (AUTHOR), Alonso-Gordoa, Teresa5 (AUTHOR), Garcia-Carbonero, Rocio6,7,8 (AUTHOR), San-Roman-Gil, Maria6 (AUTHOR), Llana, Belen9 (AUTHOR), Jimenez-Fonseca, Paula10 (AUTHOR), Benavent Viñuales, Marta11 (AUTHOR), Ansquer, Catherine12 (AUTHOR), Baudin, Eric13 (AUTHOR), Lepage, Come14 (AUTHOR), del Olmo-García, Maribel15,16 (AUTHOR), Ruffinelli, José Carlos17 (AUTHOR), Beron, Amandine18 (AUTHOR), Haissaguerre, Magalie19 (AUTHOR), Deshayes, Emmanuel20 (AUTHOR), Taïeb, David21 (AUTHOR) |
| Source: | BMC Cancer. 4/4/2025, Vol. 25 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-13941-3 |
